It means the plan should be reviewed carefully by a physician who can evaluate risks, benefits, alternatives, monitoring needs, and whether another weight loss approach may be safer
Who can take them Wegovy is approved for adults with a BMI of 30+ or 27+ and a weight-related condition, like high blood pressure or high cholesterol
Compounded GLP-1s, on the other hand, are non-brand-name versions prepared by compounding pharmacies that arent affiliated with the original drug manufacturers
Retatrutide remains an investigational medicinal product (IMP), meaning it is only legally available within the context of approved clinical trials
This weight loss is in better agreement with the ICP result than the model estimation, then supporting the postulate of multi-layer GSH covering